REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $716,668 | -22.1% | 43,540 | -5.4% | 0.00% | 0.0% |
Q2 2023 | $919,900 | +2.9% | 46,018 | -2.6% | 0.00% | 0.0% |
Q1 2023 | $893,687 | -17.8% | 47,260 | -1.5% | 0.00% | -50.0% |
Q4 2022 | $1,087,642 | -13.2% | 47,956 | +1.2% | 0.00% | 0.0% |
Q3 2022 | $1,253,000 | +5.1% | 47,408 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $1,192,000 | -18.9% | 48,263 | +9.0% | 0.00% | 0.0% |
Q1 2022 | $1,469,000 | -7.0% | 44,269 | -8.3% | 0.00% | 0.0% |
Q4 2021 | $1,579,000 | -20.5% | 48,296 | +1.9% | 0.00% | -33.3% |
Q3 2021 | $1,986,000 | -6.1% | 47,386 | -12.9% | 0.00% | 0.0% |
Q2 2021 | $2,115,000 | +6.3% | 54,434 | -6.7% | 0.00% | 0.0% |
Q1 2021 | $1,990,000 | -14.7% | 58,343 | +13.4% | 0.00% | 0.0% |
Q4 2020 | $2,334,000 | +64.8% | 51,457 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $1,416,000 | -24.5% | 51,457 | +1.1% | 0.00% | -33.3% |
Q2 2020 | $1,875,000 | +14.8% | 50,903 | +1.0% | 0.00% | -25.0% |
Q1 2020 | $1,633,000 | -21.4% | 50,418 | -0.6% | 0.00% | 0.0% |
Q4 2019 | $2,078,000 | +12.2% | 50,718 | -2.5% | 0.00% | 0.0% |
Q3 2019 | $1,852,000 | -29.8% | 52,018 | +1.2% | 0.00% | -20.0% |
Q2 2019 | $2,640,000 | -6.2% | 51,396 | +4.6% | 0.01% | -16.7% |
Q1 2019 | $2,815,000 | +33.7% | 49,118 | -2.2% | 0.01% | +20.0% |
Q4 2018 | $2,106,000 | -42.4% | 50,210 | +3.6% | 0.01% | -28.6% |
Q3 2018 | $3,658,000 | +16.5% | 48,448 | +10.7% | 0.01% | 0.0% |
Q2 2018 | $3,139,000 | +148.3% | 43,747 | +3.3% | 0.01% | +133.3% |
Q1 2018 | $1,264,000 | -12.3% | 42,353 | -2.4% | 0.00% | 0.0% |
Q4 2017 | $1,442,000 | -0.6% | 43,382 | -1.5% | 0.00% | 0.0% |
Q3 2017 | $1,451,000 | +50.7% | 44,022 | -9.7% | 0.00% | +50.0% |
Q2 2017 | $963,000 | +25.1% | 48,775 | +22.3% | 0.00% | 0.0% |
Q1 2017 | $770,000 | -0.6% | 39,875 | -4.5% | 0.00% | 0.0% |
Q4 2016 | $775,000 | +29.4% | 41,775 | -2.3% | 0.00% | +100.0% |
Q3 2016 | $599,000 | +76.2% | 42,775 | +0.7% | 0.00% | 0.0% |
Q2 2016 | $340,000 | +102.4% | 42,475 | +173.3% | 0.00% | – |
Q1 2016 | $168,000 | -24.7% | 15,540 | +15.5% | 0.00% | -100.0% |
Q4 2015 | $223,000 | – | 13,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |